HeartBeam, Inc. Stock Analysis & AI Score
HeartBeam, Inc. (BEAT) has an ST Score of 48.3 (C+), driven by its Financial Strength (A) and held back by its Momentum (D+). Analysts rate it Buy with a $2.00 price target (+427.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Specialties |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
HeartBeam, Inc. (BEAT) has an ST Score of 48.3 (C+), driven by its Financial Strength (A) and held back by its Momentum (D+). Analysts rate it Buy with a $2.00 price target (+427.7% upside).
- Strongest
- Financial StrengthA
- Weakest
- MomentumD+
All factor grades
- Financial StrengthA
- ForecastB+
- ValuationB
- GrowthC+
- ProfitabilityC-
- MomentumD+
- Piotroski2/9
Contact
BEAT stock: frequently asked questions
What is BEAT's ST Score?
HeartBeam, Inc. (BEAT) has an ST Score of 48.3 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is BEAT a buy, hold, or sell?
Analysts rate BEAT a Buy, with a price target of $2.00 (+427.7% vs the current price). Our ST Score grades it C+ (48.3/100). The ST Score is a data-driven signal, not a recommendation.
What are BEAT's factor grades?
Valuation B, Profitability C-, Financial Strength A, Momentum D+, Growth C+, Forecast B+.
What is BEAT's valuation grade?
HeartBeam, Inc. (BEAT) earns a valuation grade of B, measured against Medical - Specialties peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is BEAT's growth grade?
HeartBeam, Inc. (BEAT) earns a growth grade of C+, measured against Medical - Specialties peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is BEAT's profitability grade?
HeartBeam, Inc. (BEAT) earns a profitability grade of C-, measured against Medical - Specialties peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is BEAT's financial strength grade?
HeartBeam, Inc. (BEAT) earns a financial strength grade of A, measured against Medical - Specialties peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for BEAT?
The average analyst price target for HeartBeam, Inc. (BEAT) is $2.00 from 13 analysts, which is +427.7% versus the recent price of $0.38.
What is BEAT's Piotroski score?
HeartBeam, Inc. (BEAT) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.